These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12763374)

  • 1. Constitutive over-expression of the insulin receptor substrate-1 causes functional up-regulation of Fas receptor.
    Wiedmann M; Tamaki S; Silberman R; de la Monte SM; Cousens L; Wands JR
    J Hepatol; 2003 Jun; 38(6):803-10. PubMed ID: 12763374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GTK tyrosine kinase-induced alteration of IRS-protein signalling in insulin producing cells.
    Annerén C; Welsh M
    Mol Med; 2002 Nov; 8(11):705-13. PubMed ID: 12520087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin signaling through insulin receptor substrate 1 and 2 in normal liver development.
    Khamzina L; Gruppuso PA; Wands JR
    Gastroenterology; 2003 Aug; 125(2):572-85. PubMed ID: 12891559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol inhibits hepatocyte proliferation in insulin receptor substrate 1 transgenic mice.
    Mohr L; Tanaka S; Wands JR
    Gastroenterology; 1998 Dec; 115(6):1558-65. PubMed ID: 9834285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice.
    Leu JI; Crissey MA; Taub R
    J Clin Invest; 2003 Jan; 111(1):129-39. PubMed ID: 12511596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted hepatic overexpression of human IRS-1: postnatal effects in the developing mouse.
    Giannone PJ; Abu Dayyeh BK; Bienieki TC; Wands JR; Gruppuso PA
    Biochim Biophys Acta; 2004 May; 1672(2):112-9. PubMed ID: 15110093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis.
    Tanaka S; Wands JR
    Cancer Res; 1996 Aug; 56(15):3391-4. PubMed ID: 8758899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C; Valverde AM; Kahn CR; Benito M
    Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver.
    Longato L; de la Monte S; Kuzushita N; Horimoto M; Rogers AB; Slagle BL; Wands JR
    Hepatology; 2009 Jun; 49(6):1935-43. PubMed ID: 19475691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of insulin receptor substrate-1, but not insulin receptor substrate-2, protects a T cell hybridoma from activation-induced cell death.
    Li L; Qi X; Williams M; Shi Y; Keegan AD
    J Immunol; 2002 Jun; 168(12):6215-23. PubMed ID: 12055235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 prevents fas-induced liver injury through up-regulation of epidermal growth factor receptor.
    Li G; Han C; Xu L; Lim K; Isse K; Wu T
    Hepatology; 2009 Sep; 50(3):834-43. PubMed ID: 19585617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
    de la Monte SM; Tamaki S; Cantarini MC; Ince N; Wiedmann M; Carter JJ; Lahousse SA; Califano S; Maeda T; Ueno T; D'Errico A; Trevisani F; Wands JR
    J Hepatol; 2006 May; 44(5):971-83. PubMed ID: 16564107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRS-1 transgenic mice show increased epididymal fat mass and insulin resistance.
    Murata Y; Tsuruzoe K; Kawashima J; Furukawa N; Kondo T; Motoshima H; Igata M; Taketa K; Sasaki K; Kishikawa H; Kahn CR; Toyonaga T; Araki E
    Biochem Biophys Res Commun; 2007 Dec; 364(2):301-7. PubMed ID: 17950694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol inhibition of insulin signaling in hepatocellular carcinoma cells.
    Banerjee K; Mohr L; Wands JR; de la Monte SM
    Alcohol Clin Exp Res; 1998 Dec; 22(9):2093-101. PubMed ID: 9884156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the Shb SH2 domain-protein in insulin-producing cells leads to altered signaling through the IRS-1 and IRS-2 proteins.
    Welsh N; Makeeva N; Welsh M
    Mol Med; 2002 Nov; 8(11):695-704. PubMed ID: 12520086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes.
    Valverde AM; Fabregat I; Burks DJ; White MF; Benito M
    Hepatology; 2004 Dec; 40(6):1285-94. PubMed ID: 15565601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation.
    Liang L; Jiang J; Frank SJ
    Endocrinology; 2000 Sep; 141(9):3328-36. PubMed ID: 10965905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A specific increased expression of insulin receptor substrate 2 in pancreatic beta-cell lines is involved in mediating serum-stimulated beta-cell growth.
    Schuppin GT; Pons S; Hügl S; Aiello LP; King GL; White M; Rhodes CJ
    Diabetes; 1998 Jul; 47(7):1074-85. PubMed ID: 9648831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes.
    Tanaka S; Mohr L; Schmidt EV; Sugimachi K; Wands JR
    Hepatology; 1997 Sep; 26(3):598-604. PubMed ID: 9303488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.